Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model.
Alteration in normal hippocampal (HPC) function attributed to reduced parvalbumin (PV) expression has been consistently reported in schizophrenia patients and in animal models of schizophrenia. However, it is unclear whether there is an overall loss of interneurons as opposed to a reduction in activity-dependent PV content. Co-expression of PV and the constitutively expressed substance P (SP)-receptor protein has been utilized in other models to ascertain the degree of cell survival, as opposed to reduction in activity-dependent PV content, in the HPC. The present study measured the co-expression of PV and SP-receptors in the dentate and dorsal and ventral CA3 subregions of the HPC in the methylazoymethanol acetate (MAM) rat neurodevelopmental model of schizophrenia. In addition, these changes were compared at the post-natal day 27 (PND27) and post-natal day 240 (PND > 240) time points. Brains from PND27 and PND > 240 MAM (n = 8) and saline (SAL, n = 8) treated offspring were immunohistochemically processed for the co-expression of PV and SP-receptors. The dorsal dentate, dorsal CA3 and ventral CA3 subregions of PND27 and PND > 240 MAM rats demonstrated significant reductions in PV but not SP-receptor expression, signifying a loss of PV-content. In contrast, in the ventral dentate the co-expression of PV and SP-receptors was significantly reduced only in PND > 240 MAM animals, suggesting a reduction in cell number. While MAM-induced reduction of PV content occurs in CA3 of dorsal and ventral HPC, the most substantial loss of interneuron number is localized to the ventral dentate of PND > 240 animals. The disparate loss of PV in HPC subregions likely impacts intra-HPC network activity in MAM rats.
Departments of Neuroscience, Psychiatry and Psychology,University of Pittsburgh,Pittsburgh, PA 15260,USA.
Kathryn M
KM
Gill
Departments of Neuroscience, Psychiatry and Psychology,University of Pittsburgh,Pittsburgh, PA 15260,USA.
Anthony A
AA
Grace
D000367:Age Factors; D000704:Analysis of Variance; D000818:Animals; D016923:Cell Death / Q000187:drug effects; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000187:drug effects; D006624:Hippocampus / Q000473:pathology*; D008746:Methylazoxymethanol Acetate / Q000633:toxicity; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D009498:Neurotoxins / Q000633:toxicity; D010320:Parvalbumins / Q000378:metabolism*; D051381:Rats; D018040:Receptors, Neurokinin-1 / Q000378:metabolism*; D012559:Schizophrenia / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology*
D009498:Neurotoxins; D010320:Parvalbumins; D018040:Receptors, Neurokinin-1; D008746:Methylazoxymethanol Acetate